Retatrutide Raw Powder
Retatrutide is an experimental triple-agonist weight-loss and diabetes medication developed by Eli Lilly. By targeting GLP-1, GIP, and glucagon receptors, it reduces appetite, limits food intake, and increases fat breakdown. Clinical trials show an average weight loss of up to 24%, making it one of the most potent therapies in development.


